ResMed (WBO:RMD) Total Liabilities : €2,010 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is ResMed Total Liabilities?

ResMed's Total Liabilities for the quarter that ended in Mar. 2024 was €2,010 Mil.

ResMed's quarterly Total Liabilities declined from Sep. 2023 (€2,333.51 Mil) to Dec. 2023 (€2,222.11 Mil) and declined from Dec. 2023 (€2,222.11 Mil) to Mar. 2024 (€2,009.87 Mil).

ResMed's annual Total Liabilities increased from Jun. 2021 (€1,529.23 Mil) to Jun. 2022 (€1,641.41 Mil) and increased from Jun. 2022 (€1,641.41 Mil) to Jun. 2023 (€2,419.93 Mil).

ResMed Total Liabilities Historical Data

The historical data trend for ResMed's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Total Liabilities Chart

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

1,801.41

1,856.23

1,529.23

1,641.41

2,419.93

ResMed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,597.80	2,419.93	2,333.51	2,222.11	2,009.87

ResMed Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ResMed's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	700.126	+	(1428.884	+	97.237
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	193.679	+	0)
	=	2,420

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	6231.826	-	3811.9
	=	2,420

ResMed's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	711.188	+	(1042.691	+	54.931
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	201.061	+	0)
	=	2,010

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	6269.397	-	4259.526
	=	2,010

ResMed Total Liabilities Related Terms

Thank you for viewing the detailed overview of ResMed's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (WBO:RMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (WBO:RMD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.